146 related articles for article (PubMed ID: 17586589)
41. Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort.
Nicaise-Roland P; Nogueira L; Demattei C; de Chaisemartin L; Rincheval N; Cornillet M; Grootenboer-Mignot S; Dieudé P; Dougados M; Cantagrel A; Meyer O; Serre G; Chollet-Martin S
Ann Rheum Dis; 2013 Mar; 72(3):357-62. PubMed ID: 22580581
[TBL] [Abstract][Full Text] [Related]
42. Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities.
Ioan-Facsinay A; el-Bannoudi H; Scherer HU; van der Woude D; Ménard HA; Lora M; Trouw LA; Huizinga TW; Toes RE
Ann Rheum Dis; 2011 Jan; 70(1):188-93. PubMed ID: 20736390
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic performances of anti-cyclic citrullinated peptides antibody and antifilaggrin antibody in Korean patients with rheumatoid arthritis.
Choi SW; Lim MK; Shin DH; Park JJ; Shim SC
J Korean Med Sci; 2005 Jun; 20(3):473-8. PubMed ID: 15953872
[TBL] [Abstract][Full Text] [Related]
44. The anti-mutated citrullinated vimentin response classifies patients with rheumatoid arthritis into broad and narrow responders.
Engelmann R; Brandt J; Eggert M; Karberg K; Krause A; Neeck G; Mueller-Hilke B
J Rheumatol; 2009 Dec; 36(12):2670-4. PubMed ID: 19884278
[TBL] [Abstract][Full Text] [Related]
45. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI
Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044
[TBL] [Abstract][Full Text] [Related]
46. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
Us D; Gülmez D; Hasçelik G
Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
[TBL] [Abstract][Full Text] [Related]
47. Citrullinated peptide and its relevance to rheumatoid arthritis: an update.
Luban S; Li ZG
Int J Rheum Dis; 2010 Oct; 13(4):284-7. PubMed ID: 21199462
[TBL] [Abstract][Full Text] [Related]
48. Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.
Martínez G; Gómez JA; Bang H; Martínez-Gamboa L; Roggenbuck D; Burmester GR; Torres B; Prada D; Feist E
Rheumatol Int; 2016 Jun; 36(6):781-91. PubMed ID: 27038800
[TBL] [Abstract][Full Text] [Related]
49. Application of synthetic peptides for detection of anti-citrullinated peptide antibodies.
Trier NH; Holm BE; Slot O; Locht H; Lindegaard H; Svendsen A; Nielsen CT; Jacobsen S; Theander E; Houen G
Peptides; 2016 Feb; 76():87-95. PubMed ID: 26796582
[TBL] [Abstract][Full Text] [Related]
50. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
[TBL] [Abstract][Full Text] [Related]
51. Presence and diagnostic performances of IgA class antibodies to mutated citrullinated vimentin in rheumatoid arthritis.
Sghiri R; Khalifa O; Bouajina E; Ben Haj Slama F; Baccouche K; Ben Fredj H; Gaha R; Boukadida J
Joint Bone Spine; 2010 May; 77(3):279-80. PubMed ID: 20378382
[No Abstract] [Full Text] [Related]
52. Meta-analysis: diagnostic accuracy of the citrullinated peptides derived from fibrinogen and vimentin in rheumatoid arthritis.
Li X; Wang Z; Yi H; Xie J; Zhu N
Clin Rheumatol; 2020 Apr; 39(4):1111-1120. PubMed ID: 31858337
[TBL] [Abstract][Full Text] [Related]
53. Anti-cyclic citrullinated peptide antibodies: a comparison of different assays for the diagnosis of rheumatoid arthritis.
Debaugnies F; Servais G; Badot V; Noubouossie D; Willems D; Corazza F
Scand J Rheumatol; 2013; 42(2):108-14. PubMed ID: 23126558
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis.
Besada E; Nikolaisen C; Nossent H
Clin Exp Rheumatol; 2011; 29(1):85-8. PubMed ID: 21269572
[TBL] [Abstract][Full Text] [Related]
55. Mutated citrullinated vimentin antibodies in rheumatoid arthritis.
Kuna AT
Clin Chim Acta; 2012 Jan; 413(1-2):66-73. PubMed ID: 22037509
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F
J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
[TBL] [Abstract][Full Text] [Related]
57. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients.
Barra L; Scinocca M; Saunders S; Bhayana R; Rohekar S; Racapé M; Coles R; Cairns E; Bell DA
Arthritis Rheum; 2013 Jun; 65(6):1439-47. PubMed ID: 23450693
[TBL] [Abstract][Full Text] [Related]
58. [Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
van Venrooij WJ; van de Putte LB
Ned Tijdschr Geneeskd; 2003 Feb; 147(5):191-4. PubMed ID: 12645351
[TBL] [Abstract][Full Text] [Related]
59. IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA.
Engelmann R; Brandt J; Eggert M; Karberg K; Krause A; Neeck G; Mueller-Hilke B
Rheumatology (Oxford); 2008 Oct; 47(10):1489-92. PubMed ID: 18703528
[TBL] [Abstract][Full Text] [Related]
60. Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis.
van Venrooij WJ; Zendman AJ; Pruijn GJ
Autoimmun Rev; 2006 Nov; 6(1):37-41. PubMed ID: 17110315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]